Related references
Note: Only part of the references are listed.Clonal analyses of refractory testicular germ cell tumors
Michael T. Barrett et al.
PLOS ONE (2019)
Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors
Ratnakar Singh et al.
CANCERS (2019)
Immunotherapy: last bullet in platinum refractory germ cell testicular cancer
Albert Semaan et al.
FUTURE ONCOLOGY (2019)
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
Christoph Oing et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus
Jing Lv et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Testicular germ cell tumor: a comprehensive review
Aalia Batool et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene
Kevin Litchfield et al.
EUROPEAN UROLOGY (2018)
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer
Beatriz Paumard-Hernandez et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice
Xiaoli Zuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
Xu Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Guangbing Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
Joanna Selfe et al.
JOURNAL OF PATHOLOGY (2018)
Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers
Brianna J. Klein et al.
EPIGENETICS (2018)
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types
Arielle L. Heeke et al.
JCO PRECISION ONCOLOGY (2018)
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor
Kevin Litchfield et al.
NATURE GENETICS (2017)
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor
Zhaoming Wang et al.
NATURE GENETICS (2017)
Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
Samuel G. Awuah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition
Robert J. Mobley et al.
CELL REPORTS (2017)
A Novel Missense Mutation of the NSD1 Gene Associated with Overgrowth in Three Generations of an Italian Family: Case Report, Differential Diagnosis, and Review of Mutations of NSD1 Gene in Familial Sotos Syndrome
Gianluigi Laccetta et al.
FRONTIERS IN PEDIATRICS (2017)
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley et al.
EUROPEAN UROLOGY FOCUS (2017)
NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas
Xiaoping Su et al.
CANCER RESEARCH (2017)
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types
Tenghui Chen et al.
BMC GENOMICS (2016)
Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors
L. Boublikova et al.
CANCER LETTERS (2016)
MAD2, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors
Alejandro Lopez-Saavedra et al.
CELL CYCLE (2016)
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
Aditya Bagrodia et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Genomic evolution and chemoresistance in germ-cell tumours
Amaro Taylor-Weiner et al.
NATURE (2016)
The genomic landscape of testicular germ cell tumours: from susceptibility to treatment
Kevin Litchfield et al.
NATURE REVIEWS UROLOGY (2016)
SETD2: an epigenetic modifier with tumor suppressor functionality
Jun Li et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort
Anand Pathak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
Wenche Kristiansen et al.
HUMAN MOLECULAR GENETICS (2015)
The NSD family of protein methyltransferases in human cancer
Theodore Vougiouklakis et al.
EPIGENOMICS (2015)
Emerging roles of ATRX in cancer
L. Ashley Watson et al.
EPIGENOMICS (2015)
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Kevin Litchfield et al.
NATURE COMMUNICATIONS (2015)
Dose-Response Analysis Using R
Christian Ritz et al.
PLOS ONE (2015)
Cisplatin resistance in germ cell tumours: models and mechanisms
C. Jacobsen et al.
ANDROLOGY (2015)
Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging
Shuya Yano et al.
CELL CYCLE (2014)
Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application
Ludmila Boublikova et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Identification of functional cooperative mutations of SETD2 in human acute leukemia
Xiaofan Zhu et al.
NATURE GENETICS (2014)
SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
Sophia X. Pfister et al.
CELL REPORTS (2014)
Correction: Transcription Factor TFAP2C Regulates Major Programs Required for Murine Fetal Germ Cell Maintenance and Haploinsufficiency Predisposes to Teratomas in Male Mice
Jana Schemmer et al.
PLoS One (2013)
A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples
J. E. Nielsen et al.
ANDROLOGIA (2012)
Biological markers of cisplatin resistance in advanced testicular germ cell tumours
Adelaida Garcia-Velasco et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
K. Oechsle et al.
ANNALS OF ONCOLOGY (2011)
The testicular germ cell tumour transcriptome
S. Alagaratnam et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2011)
Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour
C. Turnbull et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease
Rabindranath De La Fuente et al.
REPRODUCTION (2011)
The role of microenvironment in testicular germ cell tumors
Alejandro Diez-Torre et al.
CANCER BIOLOGY & THERAPY (2010)
KDR-LacZ-expressing cells are involved in ovarian and testis-specific vascular development, suggesting a role for VEGFA in the regulation of this vasculature
Rebecca C. Bott et al.
CELL AND TISSUE RESEARCH (2010)
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin
James E. Korkola et al.
BJU INTERNATIONAL (2009)
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters
W. Al Sarakbi et al.
BMC CANCER (2009)
Functional identification of genes causing estrogen independence of human breast cancer cells
Ton van Agthoven et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tuomas Tammela et al.
NATURE (2008)
Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?
L. Holmes et al.
PUBLIC HEALTH (2008)
Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: Report of 220 tumors and review of literature
Jerome Coffey et al.
GENES CHROMOSOMES & CANCER (2008)
c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma
K. Biermann et al.
JOURNAL OF PATHOLOGY (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT
LH Einhorn et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Origins and molecular biology of testicular germ cell tumors
VE Reuter
MODERN PATHOLOGY (2005)
Epidemiology of testicular cancer: an overview
MJ Garner et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins
I Jedema et al.
EXPERIMENTAL HEMATOLOGY (2004)
Somatic mutations of KIT in familial testicular germ cell tumours
EA Rapley et al.
BRITISH JOURNAL OF CANCER (2004)
Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin
I Jedema et al.
LEUKEMIA (2003)
Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia
JCY Wong et al.
HUMAN MOLECULAR GENETICS (2003)
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) - A reassessment using novel receptor-specific vascular endothelial growth factor mutants
H Gille et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
